HOG
35
-3
CCL
65
-3
MNST
51
2
EXPE
85
-3
NRG
50
-10
ILMN
70
-4
LMT
62
2
KEY
75
-3
SO
44
-4
JCI
51
-6
USB
64
-2
GLW
64
-12
DAL
70
-3
VRTX
52
3
SWK
61
-3
DD
55
-4
CCI
42
-2
AME
65
-6
PWR
62
-9
EXPD
37
-5
HOG
35
-3
CCL
65
-3
MNST
51
2
EXPE
85
-3
NRG
50
-10
ILMN
70
-4
LMT
62
2
KEY
75
-3
SO
44
-4
JCI
51
-6
USB
64
-2
GLW
64
-12
DAL
70
-3
VRTX
52
3
SWK
61
-3
DD
55
-4
CCI
42
-2
AME
65
-6
PWR
62
-9
EXPD
37
-5
Financhill
Back

Abits Group, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
29

ABTS
Abits Group, Inc.

Last Price:
$6.06
Seasonality Move:
-4.69%
Sell
48

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$36.24
Seasonality Move:
6.21%
Sell
29
Abits Group, Inc. (ABTS) is a Sell

Is Abits Group, Inc. a Buy, Sell or Hold?

  • The current Abits Group, Inc. [ABTS] share price is $5.78. The Score for ABTS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ABTS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABTS Stock Price Chart

What is Abits Group, Inc.'s stock price today?

  • The Abits Group, Inc. share price today is $5.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABTS is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $36.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

ABTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: -1943 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.71 - 6.31) Sell
Bollinger Bands (100): (4.05 - 7.75) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.99 Buy
Relative Strength Index (14 RSI): 61.17 Buy
Chaikin Money Flow: -31475 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.18 - 35.78) Buy
Bollinger Bands (100): (28.77 - 33.95) Buy

ABTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.06 Sell
20-day SMA: 5.97 Sell
50-day SMA: 6.79 Sell
200-day SMA: 4.79 Buy
8-day EMA: 6.02 Sell
20-day EMA: 6.09 Sell
50-day EMA: 6.27 Sell
200-day EMA: 5.91 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.32 Sell
20-day SMA: 34.36 Buy
50-day SMA: 33.41 Buy
200-day SMA: 33.75 Buy
8-day EMA: 35.88 Buy
20-day EMA: 34.85 Buy
50-day EMA: 33.54 Buy
200-day EMA: 34.8 Buy

Abits Group, Inc. Earnings Growth & ABTS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Abits Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):